Karin Garming-Legert

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: ORAL DISEASES. 2025
Patient-Reported Oral Symptoms and Their Impact on Well-Being After Haematopoietic Cell Transplantation
Skallsjo K; Brennan MT; Hasseus B; Ohman J; Raber-Durlacher JE; Huysmans M-CDNJM; Laheij AMGA; van Leeuwen SJM; Hovan AJ; Garming Legert K; Isom S; Kline DM; Blijlevens NMA; Johansson J-E; von Bultzingslowen I
Journal article: CASE REPORTS IN HEMATOLOGY. 2025;2025(1):2622648
Rare Oral Manifestations of Systemic Amyloidosis: A Case Report
Barazanji S; Herrera JG; Garming-Legert K
Article: SUPPORTIVE CARE IN CANCER. 2024;32(10):703
Postoperative bleeding after dentoalveolar surgery in patients with thrombocytopenia-are prophylactic platelet transfusions necessary?
Lundstrom J; Wiqvist S; Jadersten M; Tollemar V; Legert KG
Article: LANCET REGIONAL HEALTH-EUROPE. 2024;42:100925
Morbidity and mortality among children, adolescents, and young adults with cancer over six decades: a Swedish population-based cohort study (the Rebuc study)
Stenmarker M; Mallios P; Hedayati E; Rodriguez-Wallberg KA; Johnsson A; Alfredsson J; Ekman B; Legert KG; Borland M; Mellergard J; Eriksson M; Marteinsdottir I; Davidson T; Engerstrom L; Sandsveden M; Keskisaerkkae R; Singull M; Hubbert L
Article: SUPPORTIVE CARE IN CANCER. 2024;32(4):220
Single nucleotide polymorphisms conferring susceptibility to leukemia and oral mucositis: a multi-center pilot study of patients prior to conditioning therapy for hematopoietic cell transplant
Mougeot J-LC; Beckman MF; Alexander AS; Hovan AJ; Hasseus B; Legert KG; Johansson J-E; von Bueltzingsloewen I; Brennan MT; Mougeot FB
Article: ORAL DISEASES. 2023;29(8):3346-3359
Immunohistopathology of oral mucosal chronic graft-versus-host disease severity and duration
Tollemar V; Strom J; Tudzarovski N; Habel H; Legert KG; Heymann R; Warfvinge G; Le Blanc K; Sugars RV
Article: SUPPORTIVE CARE IN CANCER. 2023;31(10):587
Identification of single nucleotide polymorphisms (SNPs) associated with chronic graft-versus-host disease in patients undergoing allogeneic hematopoietic cell transplantation
Mougeot J-LC; Beckman MF; Hovan AJ; Hasseus B; Legert KG; Johansson J-E; von Bultzingslowen I; Brennan MT; Mougeot FB
Article: PLOS ONE. 2023;18(5):e0285615
Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study
Skallsjo K; von Bultzingslowen I; Hasseus B; Johansson J-E; Ohman J; Raber-Durlacher JE; Huysmans M-CDNJM; Laheij AMGA; van Leeuwen SJM; Hovan AJ; Garming Legert K; Nguyen HM; Turk PJ; Rozema FR; Blijlevens NMA; Brennan MT
Article: HELIYON. 2023;9(4):e15517
Grading of minor salivary gland immuno-histopathology post-allogenic hematopoietic cell transplantation
Tollemar V; Arvidsson H; Habel H; Tudzarovski N; Legert KG; Le Blanc K; Warfvinge G; Sugars RV
Article: FRONTIERS IN ORAL HEALTH. 2023;4:1087761
Dental health of patients with X-linked hypophosphatemia: A controlled study
Larsson A; Regnstrand T; Skott P; Makitie O; Bjornsdottir S; Garming-Legert K
Article: BONE MARROW TRANSPLANTATION. 2022;57(2):191-197
Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial
Walladbegi J; Henriksson R; Tavelin B; Svanberg A; Larfors G; Jadersten M; Schjesvold F; Mahdi A; Garming Legert K; Peterson DE; Jontell M
Article: ORAL DISEASES. 2021;27(5):1217-1225
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis
Garming Legert K; Ringden O; Remberger M; Torlen J; Mattsson J; Dahllof G
Article: SUPPORTIVE CARE IN CANCER. 2020;28(10):4869-4879
Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial
Kamsvag T; Svanberg A; Legert KG; Arvidson J; von Essen L; Mellgren K; Toporski J; Winiarski J; Ljungman G
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2020;26(10):1971-1979
Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis
Tollemar V; Tudzarovski N; Warfvinge G; Yarom N; Remberger M; Heymann R; Legert KG; Sugars RV
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2020;9(10):1190-1202
Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy
Boberg E; von Bahr L; Afram G; Lindstrom C; Ljungman P; Heldring N; Petzelbauer P; Legert KG; Kadri N; Le Blanc K
Journal article: ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY. 2020;129(1):e189
Level of dental disease and differences in dental treatment in stem cell transplant recipients: the OraStem study
Napodano L; Von Bültzingslöwen I; Hovan A; Huysmans MC; Raber-Durlacher JE; Hasseus B; Blijlevens N; Laheij A; Legert KG; Rozario N; Osipoff A; Johansson J-E; Howard W; Brennan MT
Article: VOX SANGUINIS. 2019;114(7):769-777
Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantation
Berglund S; Watz E; Remberger M; Legert KG; Axdorph-Nygell U; Sundin M; Uhlin M; Mattsson J
Article: CYTOMETRY PART B-CLINICAL CYTOMETRY. 2018;93A(10):1051-1059
Quantitative chromogenic immunohistochemical image analysis in cellprofiler software
Tollemar V; Tudzarovski N; Boberg E; Andren AT; Al-Adili A; Le Blanc K; Legert KG; Bottai M; Warfvinge G; Sugars RV
Article: JMIR RESEARCH PROTOCOLS. 2018;7(4):e103
Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study
Brennan MT; Hasseus B; Hovan AJ; Raber-Durlacher JE; Blijlevens NMA; Huysmans M-C; Legert KG; Johansson J-E; Moore CG; von Bultzingslowen I
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2017;106(4):471-475
Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
Remberger M; Torlen J; El Serafi I; Garming-Legert K; Bjorklund A; Ljungman P; Sundin M; Hassan M; Mattsson J
Article: HAEMATOLOGICA. 2016;101(11):1417-1425
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Journal article: BLOOD. 2015;126(23):3138
Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study
Von Bahr L; Davies L; Afram G; Modin C; Garming-Legert K; Hagglund H; Ljungman PT; Le Blanc K
Article: SUPPORTIVE CARE IN CANCER. 2015;23(6):1749-1757
The relationship between oral mucositis and levels of pro-inflammatory cytokines in serum and in gingival crevicular fluid in allogeneic stem cell recipients
Legert KG; Tsilingaridis G; Remberger M; Ringden O; Heimdahl A; Yucel-Lindberg T; Dahllof G
Article: SUPPORTIVE CARE IN CANCER. 2014;22(8):2133-2140
Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients
Legert KG; Remberger M; Ringden O; Heimdahl A; Dahllof G
Article: BLOOD. 2014;124(5):812-821
Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease
Munneke JM; Bjorklund AT; Mjosberg JM; Garming-Legert K; Bernink JH; Blom B; Huisman C; van Oers MHJ; Spits H; Malmberg K-J; Hazenberg MD
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(2):153-162
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
Ringden O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Dahllof G; Mattsson J; Ljungman P; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2012;47(3):404-410
Salivary secretion in children after fractionated or single-dose TBI
Legert KG; Remberger M; Ringden O; Heimdahl A; Dahllof G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(6):503-509
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders
Ringden O; Remberger M; Dahllof G; Garming-Legert K; Karlsson H; Svenberg P; Uhlin M; Uzunel M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: ORAL DISEASES. 2011;17(7):670-676
Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI
Garming-Legert K; Remberger M; Ringden O; Hassan M; Dahllof G
Article: ORAL ONCOLOGY. 2011;47(9):915-919
Xerostomia in children and adolescents after stem cell transplantation conditioned with total body irradiation or busulfan
Dahllof G; Wondimu B; Barr-Agholme M; Garming-Legert K; Remberger M; Ringden O
Article: ACTA OTO-LARYNGOLOGICA. 2005;125(11):1195-1202
Development and characterization of an animal model of dental sinusitis
Legert KG; Melén I; Heimdahl A; Stierna P
Visa fler

Alla övriga publikationer

Review: FRONTIERS IN IMMUNOLOGY. 2023;14:1151493
Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses
Tollemar V; Legert K; Sugars RVV
Preprint: RESEARCH SQUARE. 2022
Dental health of patients with X-linked hypophosphatemia – a controlled study
Larsson A; Regnstrand T; Skott P; Mäkitie O; Björnsdottir S; Legert KG
Letter: CYTOTHERAPY. 2018;20(5):755-758
Stromal progenitor cell modulation by thalidomide in the treatment of oral chronic graft-versus-host disease
Davies LC; Board-Davies E; Shamlou B; Boberg E; Garming-Legert K; Le Blanc K
Conference publication: BLOOD. 2017;130
Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study
Boberg E; Von Bahr L; Heldring N; Afram G; Iacobaeus E; Lindstrom C; Garming-Legert K; Ljungman P; Sugars R; Davies L; Kadri N; Le Blanc K
Conference publication: PEDIATRIC BLOOD & CANCER. 2017;64:S360-S361
Oral Cryotherapy to Reduce the Incidence of Severe Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation: Results of a Randomized Clinical Trial
Magnusson TK; von Essen L; Arvidson J; Svanberg A; Mellgren K; Garming-Legert K; Toporski J; Winiarski J; Ljungman G
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):285
Thymic function predicts response to mesenchymal stromal cell treatment in chronic GVHD
Boberg E; von Bahr L; Heldring N; Afram G; Iacobaeus E; Modin C; Garming-Legert K; Ljungman P; Sugars R; Davies L; Kadri N; Le Blanc K
Preprint: JMIR PREPRINTS. 2017
Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study (Preprint)
Brennan MT; Hasséus B; Hovan AJ; Raber-Durlacher JE; Blijlevens NM; Huysmans M-C; Garming Legert K; Johansson J-E; Moore CG; von Bültzingslöwen I
Conference publication: BONE MARROW TRANSPLANTATION. 2017;52:S234
The role of stromal dysfunction in oral chronic GVHD
Davies L; Boberg E; Board-Davies E; Shamlou B; Garming-Legert K; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2017;52:S338-S339
Toxicological side effects of fludarabin and treosulfan conditioning before allogeneic stem-cell transplantation
Mattsson J; Torlen J; El Serafi I; Legert KG; Bjorklund A; Ljungman P; Sundin M; Hassan M; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S21
A prospective randomized study comparing tacrolimus and sirolimus versus cyclosporine and methotrexate as gvhd prophylaxis in allogeneic hematopoietic stem cell transplantation
Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S410-S411
Effect of episil® oral liquid on oral mucositis severity and duration in HSCT patients
Legert KG; Svanberg A; Zuckerman T; Ram R; Kolomansky A; Romejko-Jarosinska J; Nasilowska-Adamska B
Letter: ORAL ONCOLOGY. 2015;51(12):e97-e99
Enhanced oral healing following local mesenchymal stromal cell therapy
Garming-Legert K; Tour G; Sugars R; von Bahr L; Davies LC; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S501
BASIC ORAL CARE FOR HEMATOLOGY-ONCOLOGY PATIENTS AND HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS: A POSITION PAPER FROM THE JOINT TASK FORCE OF MASCC/ISOO AND EBMT
Mank A; Quinn B; Wallhult E; Raber-Durlacher J; Elad S; Brennan MT; Saunders DP; Zadik Y; Epstein JB; Blijlevens NM; Waltimo T; Passweg JR; Correa MEP; Dahllof G; Garming-Legert KU; Logan RM; Potting CM; Shapira MY; Soga Y; Stringer J; Stokman MA; Vokurka S; Yarom N; Jensen SB
Review: SUPPORTIVE CARE IN CANCER. 2015;23(1):223-236
Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)
Elad S; Raber-Durlacher JE; Brennan MT; Saunders DP; Mank AP; Zadik Y; Quinn B; Epstein JB; Blijlevens NMA; Waltimo T; Passweg JR; Correa MEP; Dahllof G; Garming-Legert KUE; Logan RM; Potting CMJ; Shapira MY; Soga Y; Stringer J; Stokman MA; Vokurka S; Wallhult E; Yarom N; Jensen SB
Conference publication: ORAL DISEASES. 2012;18:15
Oral mucositis in patients treated with myeloablative or reduced intensity conditioning
Legert KG; Remberger M; Ringden O; Heimdahl A; Dahllof G
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(2):S280-S281
EFFECT OF BUSULFAN AND TOTAL BODY IRRADIATION ON DENTAL DEVELOPMENT AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDHOOD
Dahllof G; Wondimu B; Garming-Legert K; Remberger M; Ringden O
Doctoral thesis: 2011
Conditioning associated effects on oral mucosa and salivary function in allogeneic stem cell recipients
Garming-Legert K
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S167-S168
Improved survival after allogeneic haematopoietic stem cell transplantation in recent years
Ringden O; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S81
Dental development in children after conditioning with busulfan or total body irradiation
Dahlloef G; Garming-Legert K; Remberger M; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S85-S86
Salivary secretion after fractionated or single-dose total body irradiation
Legert KG; Dahlloef G; Remberger M; Ringden O
Review: ACTA OTO-LARYNGOLOGICA. 2004;124(6):655-663
Sinusitis of odontogenic origin: pathophysiological implications of early treatment.
Legert KG; Zimmerman M; Stierna P
Visa fler

Anställningar

Adjunkt/Övertandläkare, Odontologi, Karolinska Institutet, 2019-

Examina och utbildning

Docent, Odontologi, Karolinska Institutet, 2025
Medicine Doktorsexamen, Institutionen för odontologi, Karolinska Institutet, 2011

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI